Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia

被引：0
|
作者：
Bourne, Garrett [1 ]
Diebold, Kendall [1 ]
Espinoza-Gutarra, Manuel [2 ]
Al-Kadhimi, Zaid [1 ]
Bachiashvili, Kimo [2 ]
Rangaraju, Sravanti [1 ]
Vachhani, Pankit [3 ]
Bhatia, Ravi [1 ]
Jamy, Omer [4 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL USA
[3] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Div Hematol Oncol, Birmingham, AL USA
[4] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189853
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia
    Bourne, Garrett
    Diebold, Kendall
    Espinoza-Gutarra, Manuel
    Al-Kadhimi, Zaid
    Bachiashvili, Kimo
    Rangaraju, Sravanti
    Vachhani, Pankit
    Bhatia, Ravi
    Jamy, Omer
    LEUKEMIA RESEARCH, 2024, 139
  • [2] Intensive Induction Chemotherapy with or without Gemtuzumab Ozogamicin Among Patients with Core-Binding Factor Acute Myeloid Leukemia
    Rojek, Alexandra E.
    McCormick, Benjamin J.
    Cwykiel, Joanna
    Odetola, Oluwatobi
    Abaza, Yasmin
    Achar, Rohan
    Shallis, Rory M.
    Bradshaw, Danielle
    Standridge, Meaghan
    Kota, Vamsi K.
    Badar, Talha
    Patel, Anand Ashwin
    BLOOD, 2023, 142
  • [3] The addition of gemtuzumab ozogamicin to chemotherapy in adult patients with acute myeloid leukemia
    Kell, Jonathan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 377 - 382
  • [4] Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
    Burnett, Alan K.
    Russell, Nigel H.
    Hills, Robert K.
    Kell, Jonathan
    Freeman, Sylvie
    Kjeldsen, Lars
    Hunter, Ann E.
    Yin, John
    Craddock, Charles F.
    Dufva, Inge Hoegh
    Wheatley, Keith
    Milligan, Donald
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (32) : 3924 - 3931
  • [5] Core-Binding Factor Acute Myeloid Leukemia
    Sangle, Nikhil A.
    Perkins, Sherrie L.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2011, 135 (11) : 1504 - 1509
  • [6] Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia
    Chantepie, Sylvain P.
    Reboursiere, Emilie
    Mear, Jean-Baptiste
    Gac, Anne-Claire
    Salaun, Veronique
    Benabed, Khaled
    Cheze, Stephane
    Johnsonansah, Hyacinthe
    Macro, Margaret
    Vilque, Jean-Pierre
    Reman, Oumedaly
    LEUKEMIA & LYMPHOMA, 2015, 56 (08) : 2326 - 2330
  • [7] Treatment Patterns Among Patients with Relapsed/Refractory Core-Binding Factor Acute Myeloid Leukemia after Intensive Induction Chemotherapy
    Rojek, Alexandra E.
    McCormick, Benjamin J.
    Cwykiel, Joanna
    Odetola, Oluwatobi
    Abaza, Yasmin
    Achar, Rohan
    Shallis, Rory M.
    Bradshaw, Danielle
    Standridge, Meaghan
    Kota, Vamsi K.
    Badar, Talha
    Patel, Anand Ashwin
    BLOOD, 2023, 142
  • [8] Cladribine, High-Dose AraC, Plus Gemtuzumab Ozogamicin (CLAG-GO) As Frontline Intensive Therapy for Fit Patients with Core-Binding Factor Acute Myeloid Leukemia: Preliminary Results
    Gener-Ricos, Georgina
    Borthakur, Gautam
    Sasaki, Koji
    Tang, Guilin
    Montalban-Bravo, Guillermo
    Jabbour, Elias
    Ohanian, Maro
    Yilmaz, Musa
    Haddad, Fadi G.
    Chien, Kelly S.
    Ishizawa, Jo
    Short, Nicholas J.
    Maiti, Abhishek
    Swaminathan, Mahesh
    Garcia-Manero, Guillermo
    Daver, Naval
    DiNardo, Courtney D.
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD, 2023, 142
  • [9] CORE-BINDING FACTOR IN CHILDHOOD ACUTE MYELOID LEUKEMIA
    Kassar, O.
    Charfi, M.
    Kallel, F.
    Ghorbel, M.
    Mdhaffar, M.
    Abdejellil, N.
    Bellaaj, H.
    Hdijji, S.
    ben Othmen, T.
    Elloumi, M.
    HAEMATOLOGICA, 2015, 100 : 375 - 375
  • [10] A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia
    Kell, WJ
    Burnett, AK
    Chopra, R
    Yin, JAL
    Clark, RE
    Rohatiner, A
    Culligan, D
    Hunter, A
    Prentice, AG
    Milligan, DW
    BLOOD, 2003, 102 (13) : 4277 - 4283
12345